All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Not reported | 2004-002752-34 | A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF AGI 003 IN THE TREATMENT OF NON-CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME. | 2005-06-06 | due-trials |
Not reported | 2004-002762-38 | A randomised, double-blind, placebo-controlled study of AGI 001 in the treatment of functional dyspepsia | 2004-02-11 | due-trials |
Not reported | 2004-004230-14 | A randomised, double-blind, placebo-controlled study of AGI 001 in the treatment of irritable bowel syndrome. | 2020-12-06 | due-trials |
Not reported | 2005-000436-24 | A randomised, double-blind, placebo-controlled study of AGI 006 in the treatment of functional dyspepsia. | 2006-10-09 | due-trials |
Not reported | 2007-003553-82 | A Randomized, Double-blind, Placebo-controlled Study of AGI-003 (Arverapamil) in the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) | 2009-04-06 | due-trials |
Not reported | 2007-003849-32 | An Open-label, Roll-over Safety Study of AGI-003 (Arverapamil) in the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) | 2009-05-29 | due-trials |
Not reported | 2007-004291-39 | A randomised, multi-centre, double-blind, balanced, parallel group placebo-controlled study of AGI004 for the control of chemotherapy-induced diarrhoea. | 2008-11-04 | due-trials |